These results indicated that 4T1 and human MDA-MB-231 breast cancer cells expressed ICAM-1 and that this antigen may be used for cancer cell targeting studies for DcNPs containing G and T (referred to as GT DcNPs). Here, ICAM1 is linked to cancer.